"antimir" meaning in English

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "anti",
        "3": "miR"
      },
      "expansion": "anti- + miR",
      "name": "prefix"
    }
  ],
  "etymology_text": "From anti- + miR.",
  "forms": [
    {
      "form": "antimirs",
      "tags": [
        "plural"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {},
      "expansion": "antimir (plural antimirs)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with anti-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 June 28, Mario Notari, Julián Pulecio, Ángel Raya, “Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease”, in BioMed Research International, volume 2015, →DOI:",
          "text": "Regardless of these arguments, anti-miRNA therapeutics have recently turn into reality by the success of Phase I and Phase II clinical trials of Santaris Pharma antimir against miR-122, miravisen, which is currently in development as a cure for hepatitis C virus [ 118 ].",
          "type": "quote"
        }
      ],
      "glosses": [
        "Any agent that counters microRNA activity"
      ],
      "id": "en-antimir-en-noun-0PZEMlJ0",
      "links": [
        [
          "microRNA",
          "microRNA"
        ]
      ]
    }
  ],
  "word": "antimir"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "anti",
        "3": "miR"
      },
      "expansion": "anti- + miR",
      "name": "prefix"
    }
  ],
  "etymology_text": "From anti- + miR.",
  "forms": [
    {
      "form": "antimirs",
      "tags": [
        "plural"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {},
      "expansion": "antimir (plural antimirs)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English countable nouns",
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms prefixed with anti-",
        "English terms with quotations",
        "Pages with 1 entry",
        "Pages with entries"
      ],
      "examples": [
        {
          "ref": "2015 June 28, Mario Notari, Julián Pulecio, Ángel Raya, “Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease”, in BioMed Research International, volume 2015, →DOI:",
          "text": "Regardless of these arguments, anti-miRNA therapeutics have recently turn into reality by the success of Phase I and Phase II clinical trials of Santaris Pharma antimir against miR-122, miravisen, which is currently in development as a cure for hepatitis C virus [ 118 ].",
          "type": "quote"
        }
      ],
      "glosses": [
        "Any agent that counters microRNA activity"
      ],
      "links": [
        [
          "microRNA",
          "microRNA"
        ]
      ]
    }
  ],
  "word": "antimir"
}